genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2017
Bladder cancer
Cancer
BioClin Raises $30M to Expand Clinical Development of FGFR3 mAb
Drug Discovery
Heat Looks to Acquire 80% Stake in Immune-Oncology Firm Pelican
Cancer
PDGx Wins SBIR Contract for Assay to Inform on Checkpoint Inhibitor Therapy
Cancer
Takeda Licenses Japanese Rights to Exelixis Anticancer Drug Cabozantinib
Cancer
Novel Bladder Cancer Therapy Based on Arginine Deprivation Shows Promising Results
Cancer
Novel Technique Detects Proteins Found to be Cancer Biomarkers
Industry News
Eleven Biotherapeutics Acquires Viventia Bio
Industry News
ProMetic to Acquire Telesta Therapeutics
Cancer
Bladder Cancer Response to Therapy Revealed by Whole-Exome Sequencing
Industry News
Telesta Therapeutics Cuts 15% of Workforce
1
...
3
4
5
...
9
Page 4 of 9
Scroll Up
